Φορτώνει......
Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
Bronchodilators, including long-acting β(2)-agonists and long-acting muscarinic antagonists, are the mainstay for treatment of patients with chronic obstructive pulmonary disease (COPD) to prevent exacerbations or reduce symptoms. Formoterol is a highly selective and potent β(2)-agonist that relaxes...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7708267/ https://ncbi.nlm.nih.gov/pubmed/33273813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S273497 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|